HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. (Q40230150)
Jump to navigation
Jump to search
scientific article published on September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. |
scientific article published on September 2006 |
Statements
1 reference
HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. (English)
1 reference
Raymond M Reilly
1 reference
Meiduo Hu
1 reference
Judy Wang
1 reference
Paul Chen
1 reference
1 September 2006
1 reference
1 reference
17
1 reference
5
1 reference
1280-1287
1 reference
Identifiers
1 reference
1 reference